REAGENT or RESOURCE |
SOURCE | IDENTIFIER |
---|---|---|
Antibodies | ||
Mouse anti-BRAF | Santa Cruz | F-7: sc-5284 |
Chemicals, Peptides, and Recombinant Proteins | ||
Vemurafenib | MedChemExpress | HY-12057 |
Encorafenib | MedChemExpress | HY-15605 |
Dabrafenib | Selleckchem | S2807 |
PLX8394 | MedChemExpress | HY-18972 |
Benzyl-coelenterazine | Nanolight | 301 |
Transfectin | BioRad | 1703352 |
Deposited Data | ||
K* designs, mutational signatures | This studyAlexandrov et al. 2013 |
https://doi.org/10.7910/DVN/DA0WWK
ftp://ftp.sanger.ac.uk/pub/cancer/AlexandrovEtA |
Coding sequence for wt targets | COSMIC, Bamford et al. 2004 | http://cancer.sanger.ac.uk/cosmic |
COSMIC mutation data, version 95 | COSMIC, Bamford et al. 2004 | http://cancer.sanger.ac.uk/cosmic |
cBioPortal mutation data, version 4.0.3 | Cerami et al. 2012 | https://www.cbioportal.org/ |
Structures of the target-ligand complexes | The Protein Data Bank This study |
http://www.rcsb.org/pdb/home/home.do
https://doi.org/10.7910/DVN/DA0WWK |
OSPREY-predicted structures of the kinase:ligand complexes | This study | https://doi.org/10.7910/DVN/DA0WWK |
Experimental Models: Cell Lines | ||
HEK293T | ATCC | N/A |
Recombinant DNA | ||
KinCon PCA reporters | This paper Roeck et al, 2019 | N/A |
Software and Algorithms | ||
OSPREY 3 | Hallen et al. 2018 | https://doi.org/10.7910/DVN/DA0WWK |
Maestro Release 2021-1 | Schrödinger | https://www.schrodinger.com/products/maestro |
AmberTools21 | Case et al. 2021 | https://ambermd.org/GetAmber.php#ambertools |
GOLD version 5.8.0 | Jones et al. 1997 | https://www.ccdc.cam.ac.uk/solutions/csd-discovery/Components/Gold/ |
MOE 2015.1001 | Chemical Computing Group | https://www.chemcomp.com/ |